Back to top
more

BioDelivery Sciences International, Inc. (BDSI)

(Delayed Data from NSDQ)

$4.84 USD

4.84
695,323

+0.08 (1.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $4.85 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now?

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Protalix Finalizes Accelerated Approval Pathway for PRX-102

Protalix (PLX) successfully completes the pre-BLA meeting and gets FDA acceptance for using accelerated approval pathway for the BLA submission of Fabry disease candidate, pegunigalsidase alfa.

Madhu Goel headshot

BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View

BioDelivery (BDSI) beats earnings and sales expectations in the third quarter of 2019. The company raises its 2019 revenue guidance.

IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well

IVERIC bio's (ISEE) third-quarter earnings improve year over year. The company plans to initiate a pivotal study on Zimura for treating GA early next year.

Nitish Marwah headshot

5 Breakout Stocks for Explosive Returns

Picking breakout stocks is one of the most-favored methods for those utilizing an active investing approach since this strategy offers the promise of superlative returns.

BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 400.00% and 5.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus

The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus

Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp

Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp

Nalak Das headshot

5 Stocks With Recent Price Strength to Enhance Your Return

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Nalak Das headshot

5 Top Momentum Stocks in October That Still Have Upside Left

Possibility of at least an interim trade deal between the largest trading countries of the world boosted investors' confidence on risky assets like equities.

Here's Why Momentum Investors Will Love BioDelivery Sciences International (BDSI)

Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Moving Average Crossover Alert: BioDelivery Sciences International

BioDelivery Sciences International, Inc. (BDSI) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Will BioDelivery Sciences Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor BioDelivery Sciences.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for October 17th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2

BioDelivery (BDSI) reports earnings against expectations of loss in Q2 and raises guidance for 2019.

Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Perrigo Completes Ranir Acquisition, Raises '19 Guidance

Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.

Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance

Amarin announces strong preliminary sales of Vascepa in the second quarter. The company increases sales guidance for 2019.

Top Ranked Momentum Stocks to Buy for July 3rd

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 3rd.

Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina

Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina

Focus on 4 Liquid Picks on the Top Rung for Robust Returns

Here are four top-ranked liquid stocks that investors can cling on to for significant returns.

What Makes BioDelivery (BDSI) a New Strong Buy Stock

BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International

The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International